Effects of long-term propranolol administration on systemic and portal hemodynamics in rats in the development stage of liver cirrhosis induced by CCL4
DC Field | Value | Language |
---|---|---|
dc.contributor.author | Nishida O. | - |
dc.contributor.author | Um S.H. | - |
dc.contributor.author | Tokubayashi M. | - |
dc.contributor.author | Kimura F. | - |
dc.contributor.author | Takimoto Y. | - |
dc.contributor.author | Yoshioka H. | - |
dc.contributor.author | Inoue R. | - |
dc.contributor.author | Murakami M. | - |
dc.contributor.author | Kita T. | - |
dc.date.available | 2020-11-10T15:56:50Z | - |
dc.date.issued | 1994-00 | - |
dc.identifier.issn | 0021-4809 | - |
dc.identifier.uri | https://scholarworks.korea.ac.kr/kumedicine/handle/2020.sw.kumedicine/32748 | - |
dc.description.abstract | The effects of oral continual administration of propranolol on systemic and portal hemodynamics were studied in cirrhotic rats induced by subcutaneous injection of carbon tetrachloride. Compared with non-administered cirrhotic group, long-term administered cirrhotic group was found to have a significant decrease of portal venous pressure and intrahepatic portal resistance. But portal venous inflow and splanchnic arterial resistance were not significantly different between the two groups. Therefore, the long-term administration of propranolol decreased portal venous pressure by prevention of the elevation of intrahepatic portal resistance without affecting portal venous inflow. So we conclude that long-term administration of propranolol in the development stage of liver cirrhosis might be a good choice for treatment of portal hypertension | - |
dc.format.extent | 8 | - |
dc.language | 일본어 | - |
dc.language.iso | JAP | - |
dc.title | Effects of long-term propranolol administration on systemic and portal hemodynamics in rats in the development stage of liver cirrhosis induced by CCL4 | - |
dc.type | Article | - |
dc.publisher.location | 일본 | - |
dc.identifier.scopusid | 2-s2.0-0027931079 | - |
dc.identifier.bibliographicCitation | Japanese Archives of Internal Medicine, v.41, no.1, pp 1 - 8 | - |
dc.citation.title | Japanese Archives of Internal Medicine | - |
dc.citation.volume | 41 | - |
dc.citation.number | 1 | - |
dc.citation.startPage | 1 | - |
dc.citation.endPage | 8 | - |
dc.type.docType | Article | - |
dc.description.isOpenAccess | N | - |
dc.description.journalRegisteredClass | scopus | - |
dc.subject.keywordPlus | carbon tetrachloride | - |
dc.subject.keywordPlus | propranolol | - |
dc.subject.keywordPlus | animal experiment | - |
dc.subject.keywordPlus | animal model | - |
dc.subject.keywordPlus | article | - |
dc.subject.keywordPlus | controlled study | - |
dc.subject.keywordPlus | drug effect | - |
dc.subject.keywordPlus | liver cirrhosis | - |
dc.subject.keywordPlus | nonhuman | - |
dc.subject.keywordPlus | oral drug administration | - |
dc.subject.keywordPlus | portal hypertension | - |
dc.subject.keywordPlus | portal vein blood flow | - |
dc.subject.keywordPlus | rat | - |
dc.subject.keywordPlus | vascular resistance | - |
dc.subject.keywordAuthor | liver cirrhosis | - |
dc.subject.keywordAuthor | microsphere sampling method | - |
dc.subject.keywordAuthor | portal hypertension | - |
dc.subject.keywordAuthor | propranolol | - |
dc.subject.keywordAuthor | rat | - |
Items in ScholarWorks are protected by copyright, with all rights reserved, unless otherwise indicated.
73, Goryeodae-ro, Seongbuk-gu, Seoul, Republic of Korea (02841)82-2-2286-1265
COPYRIGHT 2020 KOREA UNIVERSITY MEDICAL LIBRARY ALL RIGHTS RESERVED.
Certain data included herein are derived from the © Web of Science of Clarivate Analytics. All rights reserved.
You may not copy or re-distribute this material in whole or in part without the prior written consent of Clarivate Analytics.